UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549



FORM 6-K


REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16

OF THE SECURITIES EXCHANGE ACT OF 1934

FOR THE MONTH OF MARCH 2021


COMMISSION FILE NUMBER 001-38976

Genmab A/S
(Exact name of Registrant as specified in its charter)

Kalvebod Brygge 43

1560 Copenhagen V

Denmark

+45 70 20 27 28
(Address of principal executive offices)


Indicate by check mark whether the registrant files or will file annual reports under cover Form 20-F or Form 40-F.

Form 20-F  Form 40-F 

Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1)

Yes  No 

Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7)

Yes  No 

This report on Form 6-K shall be deemed to be incorporated by reference in Genmab A/S’s registration statements on Form S-8 (File No. 333-232693) and to be a part thereof from the date on which this report is filed, to the extent not superseded by documents or reports subsequently filed or furnished.


SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

nthony

GENMAB A/S

BY:

/s/ Anthony Pagano

Name: Anthony Pagano

Title: Executive Vice President & Chief Financial Officer

DATE: March 22, 2021


EXHIBIT INDEX

O

Exhibit

Description of Exhibit

99.1

Company Announcement Dated March 22, 2021: Transactions in connection with share buy-back program

99.1(a)

Appendix: Transactions March 15-19


Exhibit 99.1

Graphic

Transactions in connection with share buy-back program

Company Announcement

COPENHAGEN, Denmark; March 22, 2021 – Genmab A/S (Nasdaq: GMAB). On February 23, 2021 Genmab announced the initiation of a share buy-back program to mitigate dilution from warrant exercises and to honor our commitments under our Restricted Stock Units program.

The share buy-back program is expected to be completed no later than June 30, 2021 and comprises up to 200,000 shares.

The following transactions were executed under the program from March 15, 2021 to March 19, 2021:

 

No. of shares

Average price (DKK)

Total value (DKK)

Accumulated through last announcement

42,500

 

87,286,545

March 15, 2021

4,000

2,083.98

8,335,920

March 16, 2021

2,500

2,120.92

5,302,300

March 17, 2021

March 18, 2021

3,500

7,000

2,077.70

2,065.69

7,271,950

14,459,830

March 19, 2021

5,000

2,057.23

10,286,150

Total

22,000

45,656,150

Accumulated under the program

64,500

 

132,942,695

Details of each transaction are included as an appendix to this announcement.

Following these transactions, Genmab holds 167,477 shares as treasury shares, corresponding to 0.26% of the total share capital and voting rights.

The share buy-back program is undertaken in accordance with Regulation (EU) No. 596/2014 (‘MAR’) and the Commission Delegated Regulation (EU) 2016/1052, also referred to as the “Safe Harbour Regulation.” Further details on the terms of the share buy-back program can be found in our company announcement no. 11 dated February 23, 2021.

About Genmab

Genmab is an international biotechnology company with a core purpose to improve the lives of patients with cancer. Founded in 1999, Genmab is the creator of multiple approved antibody therapeutics that are marketed by its partners. The company aims to create, develop and commercialize differentiated therapies by leveraging next-generation antibody technologies, expertise in antibody biology, translational research and data sciences and strategic partnerships. To create novel therapies, Genmab utilizes its next-generation antibody technologies, which are the result of its collaborative company culture and a deep passion for innovation. Genmab’s proprietary pipeline consists of modified antibody candidates, including bispecific T-cell engagers and next-generation immune checkpoint modulators, effector function enhanced antibodies and antibody-drug conjugates. The company is headquartered in Copenhagen, Denmark with locations in Utrecht, the Netherlands, Princeton, New Jersey, U.S. and Tokyo, Japan. For more information, please visit Genmab.com.

Genmab A/S

Tel: +45 7020 2728

Company Announcement no. 22

Kalvebod Brygge 43

Fax: +45 7020 2729

Page 1/2

21560 Copenhagen V, Denmark

www.genmab.com

CVR no. 2102 3884

LEI Code 529900MTJPDPE4MHJ122


Graphic

Transactions in connection with share buy-back program

Contact:
Marisol Peron, Senior Vice President, Global Investor Relations & Communications

T: +1 609 524 0065; E: mmp@genmab.com

For Investor Relations:

Andrew Carlsen, Senior Director, Head of Investor Relations

T: +45 3377 9558; E: acn@genmab.com


This Company Announcement contains forward looking statements. The words “believe”, “expect”, “anticipate”, “intend” and “plan” and similar expressions identify forward looking statements. Actual results or performance may differ materially from any future results or performance expressed or implied by such statements. The important factors that could cause our actual results or performance to differ materially include, among others, risks associated with pre-clinical and clinical development of products, uncertainties related to the outcome and conduct of clinical trials including unforeseen safety issues, uncertainties related to product manufacturing, the lack of market acceptance of our products, our inability to manage growth, the competitive environment in relation to our business area and markets, our inability to attract and retain suitably qualified personnel, the unenforceability or lack of protection of our patents and proprietary rights, our relationships with affiliated entities, changes and developments in technology which may render our products or technologies obsolete, and other factors. For a further discussion of these risks, please refer to the risk management sections in Genmab’s most recent financial reports, which are available on www.genmab.com and the risk factors included in Genmab’s most recent Annual Report on Form 20-F and other filings with the U.S. Securities and Exchange Commission (SEC), which are available at www.sec.gov. Genmab does not undertake any obligation to update or revise forward looking statements in this Company Announcement nor to confirm such statements to reflect subsequent events or circumstances after the date made or in relation to actual results, unless required by law.


Genmab A/S and/or its subsidiaries own the following trademarks: Genmab®; the Y-shaped Genmab logo®; Genmab in combination with the Y-shaped Genmab logo®; HuMax®; DuoBody®; DuoBody in combination with the DuoBody logo®; HexaBody®; HexaBody in combination with the HexaBody logo®; DuoHexaBody®; HexElect®; and UniBody®. Arzerra® and Kesimpta® are trademarks of Novartis AG or its affiliates. DARZALEX® and DARZALEX FASPRO® are trademarks of Janssen Pharmaceutica NV. TEPEZZA® is a trademark of Horizon Therapeutics plc.

Genmab A/S

Tel: +45 7020 2728

Company Announcement no. 22

Kalvebod Brygge 43

Fax: +45 7020 2729

Page 2/2

21560 Copenhagen V, Denmark

www.genmab.com

CVR no. 2102 3884

LEI Code 529900MTJPDPE4MHJ122


Exhibit 99.1(a)

APPENDIX

        

Share buy-back programme - Specification for March 15 to 19, 2021

        

Graphic

Volume

        

Price

        

Venue

        

Time CET

23

2067

XCSE

20210315 9:00:10.113000

4

2067

XCSE

20210315 9:00:10.113000

34

2068

XCSE

20210315 9:00:15.708000

24

2067

XCSE

20210315 9:01:32.029000

22

2064

XCSE

20210315 9:02:56.123000

25

2065

XCSE

20210315 9:04:02.827000

23

2072

XCSE

20210315 9:05:33.757000

20

2070

XCSE

20210315 9:06:24.648000

24

2069

XCSE

20210315 9:07:35.136000

19

2063

XCSE

20210315 9:08:37.760000

3

2067

XCSE

20210315 9:10:00.154000

16

2067

XCSE

20210315 9:10:00.154000

23

2072

XCSE

20210315 9:10:45.583000

19

2073

XCSE

20210315 9:12:08.136000

22

2072

XCSE

20210315 9:13:43.352000

20

2070

XCSE

20210315 9:17:32.984000

16

2070

XCSE

20210315 9:17:32.984000

24

2076

XCSE

20210315 9:19:03.238000

10

2074

XCSE

20210315 9:21:32.261000

11

2074

XCSE

20210315 9:21:32.261000

20

2075

XCSE

20210315 9:23:42.887000

3

2075

XCSE

20210315 9:23:42.904000

19

2077

XCSE

20210315 9:24:30.588000

24

2078

XCSE

20210315 9:30:21.195000

6

2078

XCSE

20210315 9:30:21.195000

9

2078

XCSE

20210315 9:30:21.195000

9

2078

XCSE

20210315 9:30:21.195000

6

2078

XCSE

20210315 9:30:21.195000

20

2080

XCSE

20210315 9:32:54.818000

19

2080

XCSE

20210315 9:35:00.911000

20

2075

XCSE

20210315 9:37:05.207000

21

2075

XCSE

20210315 9:39:37.873000

21

2080

XCSE

20210315 9:42:05.029000

28

2082

XCSE

20210315 9:46:09.805000

20

2079

XCSE

20210315 9:49:25.890000

21

2080

XCSE

20210315 9:51:53.043000

46

2081

XCSE

20210315 9:57:54.198000

19

2080

XCSE

20210315 10:00:57.075000

20

2081

XCSE

20210315 10:03:22.285000

35

2086

XCSE

20210315 10:08:32.412000

17

2088

XCSE

20210315 10:10:17.247000

2

2088

XCSE

20210315 10:10:17.566000

5

2087

XCSE

20210315 10:13:30.420000

15

2087

XCSE

20210315 10:13:30.420000

20

2084

XCSE

20210315 10:16:55.772000

20

2081

XCSE

20210315 10:20:12.175000

21

2082

XCSE

20210315 10:25:38.147000

1


Exhibit 99.1(a)

APPENDIX

        

Share buy-back programme - Specification for March 15 to 19, 2021

        

Graphic

20

2082

XCSE

20210315 10:27:03.218000

19

2080

XCSE

20210315 10:31:12.109000

30

2078

XCSE

20210315 10:35:44.416000

19

2078

XCSE

20210315 10:38:58.636000

20

2073

XCSE

20210315 10:42:56.382000

250

2070

XCSE

20210315 10:45:52.179002

20

2070

XCSE

20210315 10:46:32.642000

19

2069

XCSE

20210315 10:51:22.587000

19

2070

XCSE

20210315 10:53:34.698000

25

2070

XCSE

20210315 10:58:34.247000

19

2064

XCSE

20210315 11:02:40.835000

37

2075

XCSE

20210315 11:11:00.309000

5

2073

XCSE

20210315 11:17:13.239000

14

2073

XCSE

20210315 11:17:13.240000

19

2079

XCSE

20210315 11:19:20.336000

19

2073

XCSE

20210315 11:23:17.595000

31

2074

XCSE

20210315 11:31:51.404000

10

2074

XCSE

20210315 11:31:51.404000

23

2069

XCSE

20210315 11:37:27.087000

9

2068

XCSE

20210315 11:41:47.005000

5

2068

XCSE

20210315 11:42:00.615000

6

2068

XCSE

20210315 11:42:15.132000

19

2068

XCSE

20210315 11:47:32.890000

30

2068

XCSE

20210315 11:53:30.164000

20

2067

XCSE

20210315 11:57:13.623000

19

2069

XCSE

20210315 11:59:06.916000

19

2068

XCSE

20210315 12:03:01.800000

19

2064

XCSE

20210315 12:07:41.256000

23

2066

XCSE

20210315 12:13:45.818000

19

2069

XCSE

20210315 12:16:59.049000

19

2069

XCSE

20210315 12:23:10.368000

19

2069

XCSE

20210315 12:29:00.716000

10

2072

XCSE

20210315 12:40:15.726000

28

2072

XCSE

20210315 12:40:15.726000

20

2069

XCSE

20210315 12:46:33.464000

20

2072

XCSE

20210315 12:56:58.453000

26

2072

XCSE

20210315 12:58:46.372000

12

2071

XCSE

20210315 13:08:29.026000

7

2071

XCSE

20210315 13:08:29.026000

19

2071

XCSE

20210315 13:09:29.052000

20

2087

XCSE

20210315 13:15:03.222000

19

2079

XCSE

20210315 13:19:33.433000

19

2081

XCSE

20210315 13:25:01.523000

21

2084

XCSE

20210315 13:28:35.235000

5

2094

XCSE

20210315 13:34:35.029000

2


Exhibit 99.1(a)

APPENDIX

        

Share buy-back programme - Specification for March 15 to 19, 2021

        

Graphic

15

2094

XCSE

20210315 13:34:35.029000

12

2100

XCSE

20210315 13:40:19.687000

8

2100

XCSE

20210315 13:40:19.687000

19

2094

XCSE

20210315 13:46:41.524000

4

2087

XCSE

20210315 13:50:59.115000

11

2087

XCSE

20210315 13:50:59.115000

6

2087

XCSE

20210315 13:50:59.115000

19

2092

XCSE

20210315 13:56:21.736000

19

2087

XCSE

20210315 14:02:16.171000

15

2085

XCSE

20210315 14:07:29.147000

5

2085

XCSE

20210315 14:07:29.147000

19

2088

XCSE

20210315 14:12:53.483000

7

2085

XCSE

20210315 14:17:16.306000

13

2085

XCSE

20210315 14:17:16.323000

20

2087

XCSE

20210315 14:27:18.904000

23

2086

XCSE

20210315 14:28:18.082000

19

2094

XCSE

20210315 14:32:05.525000

19

2090

XCSE

20210315 14:36:45.758000

5

2090

XCSE

20210315 14:41:06.850000

10

2090

XCSE

20210315 14:41:06.850000

4

2090

XCSE

20210315 14:41:07.883000

19

2098

XCSE

20210315 14:45:08.764000

45

2101

XCSE

20210315 14:55:07.976000

20

2100

XCSE

20210315 14:58:21.217000

31

2103

XCSE

20210315 15:03:38.568000

3

2103

XCSE

20210315 15:03:38.568000

19

2102

XCSE

20210315 15:07:09.596000

200

2102

XCSE

20210315 15:07:09.596888

20

2100

XCSE

20210315 15:09:56.543000

24

2107

XCSE

20210315 15:12:26.233000

12

2102

XCSE

20210315 15:15:37.878000

10

2102

XCSE

20210315 15:15:37.878000

30

2102

XCSE

20210315 15:17:46.384000

6

2102

XCSE

20210315 15:17:46.384000

21

2102

XCSE

20210315 15:19:26.319000

22

2101

XCSE

20210315 15:20:53.957000

21

2094

XCSE

20210315 15:22:05.809000

56

2101

XCSE

20210315 15:26:03.909000

2

2101

XCSE

20210315 15:26:03.909000

16

2098

XCSE

20210315 15:27:57.908000

5

2098

XCSE

20210315 15:27:57.908000

22

2098

XCSE

20210315 15:29:28.432000

22

2096

XCSE

20210315 15:31:00.803000

5

2093

XCSE

20210315 15:34:52.412000

9

2093

XCSE

20210315 15:35:20.747000

3


Exhibit 99.1(a)

APPENDIX

        

Share buy-back programme - Specification for March 15 to 19, 2021

        

Graphic

7

2093

XCSE

20210315 15:35:20.747000

30

2093

XCSE

20210315 15:35:49.747000

21

2097

XCSE

20210315 15:37:42.103000

23

2095

XCSE

20210315 15:44:14.565000

10

2095

XCSE

20210315 15:44:14.565000

23

2095

XCSE

20210315 15:44:14.566000

27

2099

XCSE

20210315 15:45:36.862000

19

2095

XCSE

20210315 15:47:18.619000

19

2092

XCSE

20210315 15:50:49.564000

24

2092

XCSE

20210315 15:51:35.459000

22

2093

XCSE

20210315 15:53:32.300000

22

2093

XCSE

20210315 15:55:06.487000

24

2092

XCSE

20210315 15:57:23.451000

19

2096

XCSE

20210315 15:59:11.405000

19

2096

XCSE

20210315 16:01:34.815000

150

2093

XCSE

20210315 16:02:36.828570

20

2093

XCSE

20210315 16:03:06.031000

21

2096

XCSE

20210315 16:07:37.269000

21

2096

XCSE

20210315 16:07:42.032000

6

2096

XCSE

20210315 16:07:42.032000

9

2094

XCSE

20210315 16:10:41.444000

11

2094

XCSE

20210315 16:10:41.444000

27

2096

XCSE

20210315 16:12:50.762000

20

2098

XCSE

20210315 16:14:19.865000

20

2096

XCSE

20210315 16:17:56.300000

20

2093

XCSE

20210315 16:21:30.424000

22

2093

XCSE

20210315 16:25:15.753000

26

2091

XCSE

20210315 16:32:14.826000

21

2085

XCSE

20210315 16:37:14.612000

25

2087

XCSE

20210315 16:41:51.163000

43

2087

XCSE

20210315 16:41:51.163328

100

2087

XCSE

20210315 16:41:51.163369

7

2087

XCSE

20210315 16:41:51.163372

175

2085

XCSE

20210315 16:43:42.604365

75

2085

XCSE

20210315 16:43:42.604401

21

2082

XCSE

20210315 16:44:02.649000

1

2083

XCSE

20210315 16:45:15.764127

15

2103

XCSE

20210316 9:00:17.506000

8

2103

XCSE

20210316 9:00:20.795000

18

2103

XCSE

20210316 9:00:20.795000

8

2103

XCSE

20210316 9:00:20.795000

21

2115

XCSE

20210316 9:01:16.569000

20

2108

XCSE

20210316 9:02:40.879000

21

2108

XCSE

20210316 9:03:59.779000

19

2111

XCSE

20210316 9:05:15.888000

4


Exhibit 99.1(a)

APPENDIX

        

Share buy-back programme - Specification for March 15 to 19, 2021

        

Graphic

15

2118

XCSE

20210316 9:07:16.129000

6

2118

XCSE

20210316 9:07:18.594000

18

2118

XCSE

20210316 9:07:18.611000

20

2118

XCSE

20210316 9:08:59.410000

9

2118

XCSE

20210316 9:08:59.410000

21

2115

XCSE

20210316 9:10:30.949000

20

2111

XCSE

20210316 9:11:52.016000

23

2113

XCSE

20210316 9:14:18.293000

20

2113

XCSE

20210316 9:15:57.944000

7

2111

XCSE

20210316 9:17:59.164000

12

2111

XCSE

20210316 9:18:03.135000

20

2112

XCSE

20210316 9:20:04.917000

19

2115

XCSE

20210316 9:22:03.925000

20

2113

XCSE

20210316 9:25:12.943000

19

2110

XCSE

20210316 9:27:04.397000

19

2110

XCSE

20210316 9:29:26.064000

20

2107

XCSE

20210316 9:33:05.081000

24

2107

XCSE

20210316 9:36:07.895000

19

2110

XCSE

20210316 9:38:48.569000

29

2110

XCSE

20210316 9:43:04.394000

25

2111

XCSE

20210316 9:47:11.479000

21

2105

XCSE

20210316 9:51:04.056000

24

2106

XCSE

20210316 9:56:43.124000

19

2103

XCSE

20210316 9:57:20.722000

32

2108

XCSE

20210316 10:02:02.888000

49

2110

XCSE

20210316 10:11:17.609000

19

2110

XCSE

20210316 10:13:45.024000

20

2110

XCSE

20210316 10:17:18.653000

21

2110

XCSE

20210316 10:24:25.889000

19

2111

XCSE

20210316 10:25:00.252000

20

2112

XCSE

20210316 10:31:59.603000

31

2116

XCSE

20210316 10:35:43.099000

19

2118

XCSE

20210316 10:40:07.870000

19

2120

XCSE

20210316 10:44:00.483000

20

2124

XCSE

20210316 10:49:33.681000

27

2125

XCSE

20210316 10:54:57.385000

20

2133

XCSE

20210316 10:59:04.443000

19

2137

XCSE

20210316 11:04:01.070000

19

2132

XCSE

20210316 11:09:27.552000

1

2135

XCSE

20210316 11:14:37.386000

18

2135

XCSE

20210316 11:14:37.386000

20

2133

XCSE

20210316 11:18:39.033000

23

2133

XCSE

20210316 11:25:36.844000

19

2132

XCSE

20210316 11:29:57.128000

15

2131

XCSE

20210316 11:35:27.637000

5


Exhibit 99.1(a)

APPENDIX

        

Share buy-back programme - Specification for March 15 to 19, 2021

        

Graphic

4

2131

XCSE

20210316 11:35:27.637000

30

2131

XCSE

20210316 11:43:51.314000

12

2125

XCSE

20210316 11:48:59.911000

9

2125

XCSE

20210316 11:48:59.911000

8

2117

XCSE

20210316 11:55:08.719000

16

2117

XCSE

20210316 11:55:08.719000

20

2116

XCSE

20210316 12:01:02.913000

30

2113

XCSE

20210316 12:10:05.023000

19

2110

XCSE

20210316 12:13:35.649000

20

2114

XCSE

20210316 12:18:22.456000

28

2110

XCSE

20210316 12:29:25.901000

20

2118

XCSE

20210316 12:40:14.843000

14

2116

XCSE

20210316 12:44:56.099000

5

2116

XCSE

20210316 12:44:56.099000

14

2115

XCSE

20210316 12:49:53.321000

20

2117

XCSE

20210316 13:01:27.448000

18

2117

XCSE

20210316 13:01:27.448000

32

2120

XCSE

20210316 13:11:18.203000

19

2121

XCSE

20210316 13:18:05.147000

19

2114

XCSE

20210316 13:23:16.004000

31

2121

XCSE

20210316 13:31:19.208000

29

2122

XCSE

20210316 13:40:20.300000

19

2124

XCSE

20210316 13:46:36.870000

19

2127

XCSE

20210316 13:52:41.434000

8

2123

XCSE

20210316 13:59:32.475000

11

2123

XCSE

20210316 13:59:32.475000

20

2132

XCSE

20210316 14:05:54.626000

19

2127

XCSE

20210316 14:12:23.246000

26

2127

XCSE

20210316 14:19:48.450000

42

2127

XCSE

20210316 14:30:29.175000

18

2131

XCSE

20210316 14:35:38.650000

1

2131

XCSE

20210316 14:35:38.650000

19

2124

XCSE

20210316 14:41:18.727000

20

2130

XCSE

20210316 14:46:04.930000

20

2133

XCSE

20210316 14:50:58.231000

19

2130

XCSE

20210316 14:55:28.862000

21

2125

XCSE

20210316 15:00:14.410000

5

2129

XCSE

20210316 15:04:25.652000

5

2129

XCSE

20210316 15:04:25.667000

13

2129

XCSE

20210316 15:04:25.667000

19

2126

XCSE

20210316 15:08:16.142000

4

2126

XCSE

20210316 15:11:24.795000

16

2126

XCSE

20210316 15:11:24.795000

69

2124

XCSE

20210316 15:19:07.312000

28

2128

XCSE

20210316 15:23:03.842000

6


Exhibit 99.1(a)

APPENDIX

        

Share buy-back programme - Specification for March 15 to 19, 2021

        

Graphic

21

2128

XCSE

20210316 15:23:05.845000

21

2124

XCSE

20210316 15:25:09.438000

31

2131

XCSE

20210316 15:32:00.268000

43

2131

XCSE

20210316 15:32:00.268000

20

2129

XCSE

20210316 15:33:57.974000

20

2131

XCSE

20210316 15:36:08.678000

24

2133

XCSE

20210316 15:39:47.439000

20

2133

XCSE

20210316 15:42:02.481000

20

2133

XCSE

20210316 15:45:51.785000

24

2132

XCSE

20210316 15:46:12.972000

24

2131

XCSE

20210316 15:49:10.624000

20

2130

XCSE

20210316 15:51:15.009000

42

2133

XCSE

20210316 15:55:54.291000

17

2131

XCSE

20210316 15:58:23.457000

22

2129

XCSE

20210316 16:00:40.111000

20

2128

XCSE

20210316 16:02:53.034000

35

2131

XCSE

20210316 16:08:53.935000

20

2129

XCSE

20210316 16:09:39.513000

169

2123

XCSE

20210316 16:37:13.278029

29

2120

XCSE

20210317 9:00:06.582000

21

2110

XCSE

20210317 9:02:42.208000

20

2114

XCSE

20210317 9:04:24.233000

24

2115

XCSE

20210317 9:07:03.670000

32

2121

XCSE

20210317 9:10:05.977000

24

2114

XCSE

20210317 9:12:55.417000

21

2104

XCSE

20210317 9:17:08.602000

17

2104

XCSE

20210317 9:17:39.798671

33

2104

XCSE

20210317 9:17:41.655708

35

2109

XCSE

20210317 9:25:28.552000

11

2109

XCSE

20210317 9:25:28.576000

19

2103

XCSE

20210317 9:31:03.814000

19

2103

XCSE

20210317 9:35:30.066000

22

2098

XCSE

20210317 9:41:05.791000

9

2096

XCSE

20210317 9:41:52.416197

20

2096

XCSE

20210317 9:42:09.204386

21

2096

XCSE

20210317 9:43:02.166025

19

2096

XCSE

20210317 9:45:16.842000

20

2090

XCSE

20210317 9:52:29.305000

20

2096

XCSE

20210317 9:56:40.240000

20

2098

XCSE

20210317 10:01:10.333000

23

2101

XCSE

20210317 10:06:57.277000

19

2097

XCSE

20210317 10:12:33.246000

19

2095

XCSE

20210317 10:18:51.498000

2

2096

XCSE

20210317 10:29:18.932000

1

2096

XCSE

20210317 10:29:47.756000

7


Exhibit 99.1(a)

APPENDIX

        

Share buy-back programme - Specification for March 15 to 19, 2021

        

Graphic

1

2096

XCSE

20210317 10:29:55.180000

15

2096

XCSE

20210317 10:29:55.181000

28

2100

XCSE

20210317 10:34:09.460000

21

2095

XCSE

20210317 10:41:54.153000

5

2091

XCSE

20210317 10:46:16.396091

18

2091

XCSE

20210317 10:46:19.626273

27

2091

XCSE

20210317 10:46:19.626308

1

2091

XCSE

20210317 10:48:34.490000

21

2091

XCSE

20210317 10:48:36.318000

20

2093

XCSE

20210317 10:56:33.123000

19

2096

XCSE

20210317 11:02:37.702000

20

2087

XCSE

20210317 11:10:28.223000

19

2081

XCSE

20210317 11:18:19.924000

11

2082

XCSE

20210317 11:27:22.503000

8

2082

XCSE

20210317 11:27:22.503000

19

2085

XCSE

20210317 11:35:16.796000

11

2085

XCSE

20210317 11:43:46.221000

8

2085

XCSE

20210317 11:43:46.221000

20

2087

XCSE

20210317 11:51:59.335000

19

2086

XCSE

20210317 12:01:06.005000

23

2091

XCSE

20210317 12:09:30.510000

19

2089

XCSE

20210317 12:19:30.588000

10

2085

XCSE

20210317 12:26:10.606950

40

2085

XCSE

20210317 12:26:10.606991

15

2085

XCSE

20210317 12:31:16.035000

5

2085

XCSE

20210317 12:31:18.241000

3

2075

XCSE

20210317 12:40:21.757429

47

2075

XCSE

20210317 12:40:57.731966

19

2076

XCSE

20210317 12:43:19.424000

9

2075

XCSE

20210317 12:47:14.802011

18

2075

XCSE

20210317 12:47:26.727633

18

2075

XCSE

20210317 12:47:26.727701

5

2075

XCSE

20210317 12:47:26.727726

19

2076

XCSE

20210317 12:55:07.803000

19

2077

XCSE

20210317 13:05:08.171000

19

2072

XCSE

20210317 13:14:10.091000

19

2066

XCSE

20210317 13:23:51.640000

19

2068

XCSE

20210317 13:31:50.050000

19

2062

XCSE

20210317 13:42:37.705000

100

2060

XCSE

20210317 13:43:48.940410

50

2062

XCSE

20210317 13:43:48.940410

20

2071

XCSE

20210317 13:54:20.053000

20

2073

XCSE

20210317 14:05:36.399000

19

2073

XCSE

20210317 14:16:30.593000

19

2072

XCSE

20210317 14:23:24.990000

8


Exhibit 99.1(a)

APPENDIX

        

Share buy-back programme - Specification for March 15 to 19, 2021

        

Graphic

6

2068

XCSE

20210317 14:30:02.909834

44

2068

XCSE

20210317 14:30:04.349667

19

2066

XCSE

20210317 14:30:59.191000

19

2055

XCSE

20210317 14:40:16.125000

19

2060

XCSE

20210317 14:48:30.363000

20

2058

XCSE

20210317 14:56:02.303000

50

2058

XCSE

20210317 14:58:42.971113

20

2060

XCSE

20210317 15:02:35.577000

19

2062

XCSE

20210317 15:08:24.512000

8

2063

XCSE

20210317 15:15:40.040399

10

2063

XCSE

20210317 15:15:40.058042

15

2063

XCSE

20210317 15:15:42.037834

3

2063

XCSE

20210317 15:15:42.088034

14

2063

XCSE

20210317 15:15:45.207545

11

2063

XCSE

20210317 15:15:58.450647

6

2063

XCSE

20210317 15:15:58.450647

14

2063

XCSE

20210317 15:15:58.450647

19

2063

XCSE

20210317 15:16:26.070157

19

2062

XCSE

20210317 15:16:42.216000

20

2064

XCSE

20210317 15:17:18.954000

20

2069

XCSE

20210317 15:20:32.421000

20

2071

XCSE

20210317 15:23:22.332000

29

2068

XCSE

20210317 15:30:45.782000

20

2068

XCSE

20210317 15:31:05.268000

3

2069

XCSE

20210317 15:34:41.996000

16

2069

XCSE

20210317 15:34:41.996000

20

2074

XCSE

20210317 15:38:20.651000

19

2070

XCSE

20210317 15:43:24.975000

28

2070

XCSE

20210317 15:48:03.818000

2

2068

XCSE

20210317 15:50:26.519347

2

2068

XCSE

20210317 15:50:26.525907

8

2068

XCSE

20210317 15:50:26.603033

3

2068

XCSE

20210317 15:50:26.609621

35

2068

XCSE

20210317 15:50:27.283026

28

2070

XCSE

20210317 15:53:03.011000

20

2074

XCSE

20210317 15:56:23.567000

23

2076

XCSE

20210317 16:00:53.728000

27

2072

XCSE

20210317 16:02:59.240558

1

2072

XCSE

20210317 16:02:59.240558

5

2072

XCSE

20210317 16:02:59.266829

20

2072

XCSE

20210317 16:03:10.107261

3

2072

XCSE

20210317 16:03:10.107291

22

2072

XCSE

20210317 16:03:10.107299

20

2072

XCSE

20210317 16:03:10.139313

30

2072

XCSE

20210317 16:03:19.688579

9


Exhibit 99.1(a)

APPENDIX

        

Share buy-back programme - Specification for March 15 to 19, 2021

        

Graphic

67

2072

XCSE

20210317 16:03:19.688579

30

2072

XCSE

20210317 16:03:19.688665

18

2072

XCSE

20210317 16:03:19.710520

10

2072

XCSE

20210317 16:03:35.234232

8

2072

XCSE

20210317 16:03:35.234282

14

2072

XCSE

20210317 16:03:40.260945

1

2073

XCSE

20210317 16:03:51.162759

2

2073

XCSE

20210317 16:03:51.162759

2

2073

XCSE

20210317 16:03:51.162759

14

2073

XCSE

20210317 16:03:58.704505

36

2073

XCSE

20210317 16:03:58.704517

22

2073

XCSE

20210317 16:03:58.704562

30

2073

XCSE

20210317 16:03:58.704566

38

2073

XCSE

20210317 16:03:58.721675

50

2073

XCSE

20210317 16:03:58.721675

12

2073

XCSE

20210317 16:03:58.762646

8

2073

XCSE

20210317 16:03:59.552410

38

2073

XCSE

20210317 16:03:59.552410

40

2073

XCSE

20210317 16:04:00.396468

1

2073

XCSE

20210317 16:04:00.396496

9

2073

XCSE

20210317 16:04:13.911555

24

2073

XCSE

20210317 16:06:15.739920

20

2073

XCSE

20210317 16:06:16.150165

6

2073

XCSE

20210317 16:06:16.150194

25

2073

XCSE

20210317 16:06:16.150226

19

2073

XCSE

20210317 16:06:16.150274

50

2073

XCSE

20210317 16:06:39.307373

17

2073

XCSE

20210317 16:06:39.307435

11

2073

XCSE

20210317 16:06:39.307438

35

2073

XCSE

20210317 16:08:03.770269

15

2073

XCSE

20210317 16:08:03.770370

74

2073

XCSE

20210317 16:08:03.770384

30

2073

XCSE

20210317 16:08:03.770408

43

2073

XCSE

20210317 16:08:03.770430

10

2073

XCSE

20210317 16:08:03.788525

40

2073

XCSE

20210317 16:09:01.773333

50

2073

XCSE

20210317 16:09:01.786714

35

2073

XCSE

20210317 16:09:01.786774

40

2073

XCSE

20210317 16:09:01.786810

10

2073

XCSE

20210317 16:09:01.786911

24

2073

XCSE

20210317 16:09:01.805008

26

2073

XCSE

20210317 16:09:04.151675

25

2073

XCSE

20210317 16:09:04.154245

25

2073

XCSE

20210317 16:09:04.154295

1

2073

XCSE

20210317 16:09:04.154295

10


Exhibit 99.1(a)

APPENDIX

        

Share buy-back programme - Specification for March 15 to 19, 2021

        

Graphic

10

2073

XCSE

20210317 16:09:04.160658

30

2073

XCSE

20210317 16:09:04.160701

10

2073

XCSE

20210317 16:09:04.160750

10

2073

XCSE

20210317 16:09:04.160784

40

2073

XCSE

20210317 16:09:04.160809

50

2073

XCSE

20210317 16:09:04.173094

50

2073

XCSE

20210317 16:09:04.179404

11

2073

XCSE

20210317 16:09:04.179429

1

2073

XCSE

20210317 16:09:04.179474

80

2090

XCSE

20210318 9:00:02.384000

24

2091

XCSE

20210318 9:01:59.114000

15

2091

XCSE

20210318 9:01:59.131000

19

2088

XCSE

20210318 9:02:20.084000

32

2105

XCSE

20210318 9:05:04.793000

9

2105

XCSE

20210318 9:05:04.793000

32

2105

XCSE

20210318 9:05:04.793000

20

2109

XCSE

20210318 9:05:45.239000

20

2111

XCSE

20210318 9:06:33.689000

20

2115

XCSE

20210318 9:07:16.236000

4

2114

XCSE

20210318 9:08:06.431000

15

2114

XCSE

20210318 9:08:06.979000

1

2114

XCSE

20210318 9:08:07.603000

15

2108

XCSE

20210318 9:08:45.930000

4

2108

XCSE

20210318 9:08:46.465000

19

2105

XCSE

20210318 9:09:32.388000

1

2105

XCSE

20210318 9:09:32.942000

1

2105

XCSE

20210318 9:09:33.538000

19

2102

XCSE

20210318 9:10:15.290000

20

2100

XCSE

20210318 9:11:30.952000

8

2100

XCSE

20210318 9:11:31.509000

3

2100

XCSE

20210318 9:11:32.112000

3

2100

XCSE

20210318 9:11:32.605000

2

2105

XCSE

20210318 9:13:52.712000

32

2105

XCSE

20210318 9:13:52.712000

23

2106

XCSE

20210318 9:16:32.091000

18

2106

XCSE

20210318 9:16:32.108000

5

2104

XCSE

20210318 9:18:19.035000

19

2104

XCSE

20210318 9:18:19.035000

21

2100

XCSE

20210318 9:19:48.270000

5

2102

XCSE

20210318 9:22:54.990000

19

2102

XCSE

20210318 9:22:54.990000

24

2102

XCSE

20210318 9:24:23.085000

6

2101

XCSE

20210318 9:26:00.970000

49

2105

XCSE

20210318 9:27:17.963000

11


Exhibit 99.1(a)

APPENDIX

        

Share buy-back programme - Specification for March 15 to 19, 2021

        

Graphic

7

2112

XCSE

20210318 9:30:05.956000

16

2112

XCSE

20210318 9:30:05.956000

21

2109

XCSE

20210318 9:31:33.324000

20

2110

XCSE

20210318 9:33:18.002000

22

2106

XCSE

20210318 9:35:15.376000

22

2103

XCSE

20210318 9:37:20.438000

25

2100

XCSE

20210318 9:39:44.479000

21

2091

XCSE

20210318 9:41:30.778000

22

2087

XCSE

20210318 9:44:13.669000

5

2083

XCSE

20210318 9:46:27.065000

14

2083

XCSE

20210318 9:46:27.065000

19

2085

XCSE

20210318 9:47:48.479000

20

2085

XCSE

20210318 9:50:15.123000

22

2087

XCSE

20210318 9:52:07.891000

21

2092

XCSE

20210318 9:55:01.766000

3

2092

XCSE

20210318 9:55:01.766000

20

2095

XCSE

20210318 9:56:22.885000

22

2088

XCSE

20210318 9:58:23.440000

22

2094

XCSE

20210318 10:00:18.842000

19

2094

XCSE

20210318 10:02:20.201000

4

2094

XCSE

20210318 10:02:20.201000

19

2093

XCSE

20210318 10:04:07.193000

20

2091

XCSE

20210318 10:07:07.662000

20

2088

XCSE

20210318 10:08:05.216000

5

2085

XCSE

20210318 10:10:22.399000

19

2085

XCSE

20210318 10:10:22.399000

20

2084

XCSE

20210318 10:13:13.724000

20

2086

XCSE

20210318 10:16:30.022000

17

2084

XCSE

20210318 10:17:52.380000

3

2084